NCT06525740View on ClinicalTrials.gov

Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

September 3, 2024

Primary Completion Date

September 1, 2029

Study Completion Date

September 1, 2029

Conditions
Malignant Female Reproductive System Neoplasm
Interventions
DRUG

Hydromorphone

Given IT

DRUG

Methadone

Given IV

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06525740 - Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery | Biotech Hunter | Biotech Hunter